Search

Elanco Animal Health Inc

Fermé

SecteurSoins de santé

25.09 2.79

Résumé

Variation du prix de l'action

24h

Actuel

Min

23.99

Max

24.52

Chiffres clés

By Trading Economics

Revenu

-3M

54M

Ventes

-3M

1.4B

P/E

Moyenne du Secteur

372.714

57.371

BPA

0.34

Marge bénéficiaire

3.947

Employés

9,400

EBITDA

-42M

274M

Recommandations

By TipRanks

Recommandations

Achat Fort

Prévisions sur 12 Mois

+28.3% upside

Dividendes

By Acuity

Prochains Résultats

4 nov. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-1.1B

12B

Ouverture précédente

22.3

Clôture précédente

25.09

Sentiment de l'Actualité

By Acuity

37%

63%

128 / 340 Classement par Healthcare

Elanco Animal Health Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

24 août 2026, 19:36 UTC

Elanco Animal Health Inc. shares are trading higher during Monday's session, reaching a peak earlier in the day within its one-month trading range.

21 août 2026, 23:46 UTC

Elanco Animal Health shares are higher in after-market trading, reflecting unusual activity despite no specific news to explain the movement.

20 août 2026, 23:21 UTC

Elanco Animal Health Inc trades higher in after-market hours, despite broader market pressures from rising bond yields and geopolitical risks.

19 août 2026, 20:06 UTC

Correlated Moves

Elanco Animal Health is gaining today, supported by a notable increase in the Forest Products sector, which has risen significantly during the session.

17 août 2026, 19:26 UTC

Elanco Animal Health shares are lower today, trading flat since Friday's close. The stock remains below its 20-day moving average with no specific news driving the decline.

14 août 2026, 23:36 UTC

Elanco Animal Health shares declined in after-market trading, remaining below the 20-day moving average amid concerns over a surprising drop in U.S. retail sales.

13 août 2026, 20:06 UTC

Elanco Animal Health Inc shares are higher today amid a broader market uptrend. The stock remains below its 20-day moving average.

12 août 2026, 19:51 UTC

Elanco Animal Health shares are declining today, despite high trading volume. No specific news was identified to explain the downward movement.

11 août 2026, 19:36 UTC

News

Elanco Animal Health receives FDA Emergency Use Authorization for CLiK Extra wound spray to combat New World screwworm infestations, boosting shares during Tuesday's session.

10 août 2026, 23:06 UTC

Elanco Animal Health shares are higher in after-market trading, following notable volatility during the session. The stock remains below its 20-day moving average.

7 août 2026, 23:36 UTC

Elanco Animal Health shares are higher in after-market trading, following a session spike despite no specific company news identified.

6 août 2026, 23:36 UTC

Elanco Animal Health Inc shares are higher in after-market hours. No specific news was identified to explain this movement, which shows routine trading.

5 août 2026, 19:52 UTC

News

Elanco Animal Health reported second-quarter revenue of $1.368 billion and raised its full-year adjusted EPS guidance to between $1.10 and $1.16. Shares are higher.

4 août 2026, 23:01 UTC

Elanco Animal Health Inc shares are higher in after-market hours, recovering from three days of declines amid broader market optimism and easing oil prices.

3 août 2026, 20:02 UTC

Elanco Animal Health is trading lower amid a broader market decline, reflecting negative sentiment in the pharmaceuticals sector. No specific news was identified.

31 juil. 2026, 23:01 UTC

Elanco Animal Health Inc shares are lower in after-market hours, trading near the lower end of their one-month range with no specific news identified.

30 juil. 2026, 16:11 UTC

Elanco Animal Health is lower today, influenced by declines in the Pharmaceuticals sub-sector. The stock remains above its 20-day moving average.

29 juil. 2026, 18:14 UTC

Elanco Animal Health shares are higher today, breaking a pattern of recent daily closes. No specific news was identified to explain the movement.

28 juil. 2026, 18:26 UTC

Correlated Moves
News

Bank of America maintains its buy rating on Elanco Animal Health, citing a favorable catalyst profile ahead of second-quarter earnings. Shares are higher today.

27 juil. 2026, 18:36 UTC

Elanco Animal Health is trading higher, reflecting positive market conditions, though no specific news was identified to explain the price movement.

24 juil. 2026, 19:26 UTC

Elanco Animal Health shares are higher, reflecting broader market dynamics amid a pullback in crude oil prices and easing energy-related pressures.

23 juil. 2026, 10:16 UTC

Elanco Animal Health is trading roughly flat in pre-market hours, despite broader market declines influenced by earnings reports and rising oil prices.

22 juil. 2026, 19:25 UTC

News

Elanco Animal Health trades higher as Morgan Stanley raises price target to $26. New data shows Credelio Quattro effectively kills ticks faster than competitors.

21 juil. 2026, 19:26 UTC

Elanco Animal Health shares are higher, continuing a positive trend since Monday. Broader market optimism follows strong earnings from General Motors and Novartis.

20 juil. 2026, 19:46 UTC

Elanco Animal Health Inc. shares are lower today, continuing a decline since Friday's close, despite an earlier peak in the session.

Comparaison

Variation de prix

Elanco Animal Health Inc prévision

Objectif de Prix

By TipRanks

28.3% hausse

Prévisions sur 12 Mois

Moyen 31.33 USD  28.3%

Haut 34 USD

Bas 26 USD

Basé sur 12 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

12 ratings

11

Achat

1

Maintien

0

Vente

Sentiment

By Acuity

128 / 340Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Elanco Animal Health Inc

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
help-icon Live chat